Neurogenesis is the process of generating new neurons from neural progenitor cells and stem cells throughout the nervous system. While historically believed to be restricted to embryonic development, it is now well-established that neurogenesis continues in specific regions of the adult mammalian brain, particularly the hippocampus and olfactory bulb. This persistent capacity for neuronal renewal has profound implications for brain plasticity, cognitive function, and the pathophysiology of neurodegenerative diseases.
• Neural Stem Cell Proliferation and Differentiation: Adult neurogenesis begins with the activation and proliferation of neural stem cells (NSCs) and neural progenitor cells (NPCs) residing in neurogenic niches. These cells undergo asymmetric division, producing both self-renewing stem cells and differentiated progeny. The process involves sequential stages: proliferation of radial glia-like (RGL) cells, intermediate progenitor expansion, neuroblast migration, and final maturation into functionally integrated neurons. Key transcription factors including NeuroD1, neurogenin, and Pax6 regulate these developmental transitions (PMID:17873885).
Neurogenesis is the process of generating new neurons from neural progenitor cells and stem cells throughout the nervous system. While historically believed to be restricted to embryonic development, it is now well-established that neurogenesis continues in specific regions of the adult mammalian brain, particularly the hippocampus and olfactory bulb. This persistent capacity for neuronal renewal has profound implications for brain plasticity, cognitive function, and the pathophysiology of neurodegenerative diseases.
• Neural Stem Cell Proliferation and Differentiation: Adult neurogenesis begins with the activation and proliferation of neural stem cells (NSCs) and neural progenitor cells (NPCs) residing in neurogenic niches. These cells undergo asymmetric division, producing both self-renewing stem cells and differentiated progeny. The process involves sequential stages: proliferation of radial glia-like (RGL) cells, intermediate progenitor expansion, neuroblast migration, and final maturation into functionally integrated neurons. Key transcription factors including NeuroD1, neurogenin, and Pax6 regulate these developmental transitions (PMID:17873885).
• Hippocampal Neurogenesis and Memory Formation: The dentate gyrus of the hippocampus represents the most thoroughly characterized neurogenic region in the adult brain. Newly generated neurons in this region undergo a critical maturation period (2-3 weeks) during which they exhibit heightened synaptic plasticity and reduced GABAergic inhibition, rendering them particularly responsive to learning-related activity. Emerging evidence suggests that young neurons contribute specifically to pattern separation and cognitive flexibility, processes essential for encoding new contextual memories and discriminating between similar experiences (PMID:23658582).
• Integration into Existing Circuits: Newly born neurons must extend axons and dendrites, establish synaptic connections, and become functionally integrated into existing neural networks. This process involves activity-dependent mechanisms, including NMDA receptor signaling and BDNF-TrkB pathway activation. The stage of neural development at which new neurons are recruited into functional circuits appears critical—early-stage immature neurons can be preferentially activated by novel learning experiences, suggesting a developmental window for memory encoding (PMID:21068766).
• Regulation by Environmental and Physiological Factors: Adult neurogenesis is highly responsive to multiple intrinsic and extrinsic factors. Physical exercise substantially enhances hippocampal neurogenesis through BDNF signaling and increased vascularization. Environmental enrichment, cognitive stimulation, and certain pharmacological agents (notably antidepressants via serotonin 5-HT1A receptors) promote neurogenesis, while aging, stress, inflammation, and sleep deprivation suppress it. These modulatory factors link neurogenesis to behavioral outcomes and disease states (PMID:16618002).
• Olfactory Bulb Neurogenesis: The rostral migratory stream (RMS) continuously supplies newborn interneurons to the olfactory bulb throughout life. These young neurons integrate into existing olfactory circuits and contribute to olfactory learning and odor discrimination. The olfactory bulb represents a unique system where neurogenesis directly contributes to sensory processing and behavioral adaptation, providing a model for understanding how structural plasticity translates into functional improvements (PMID:19147841).
Impaired neurogenesis is increasingly recognized as a contributing factor to cognitive decline in neurodegenerative diseases and normal aging. In Alzheimer's disease (AD), multiple mechanisms suppress hippocampal neurogenesis: amyloid-beta (Aβ) oligomers directly inhibit NSC proliferation and promote neural progenitor apoptosis, tau pathology disrupts cellular signaling pathways essential for neuronal development, and neuroinflammation driven by activated microglia and astrocytes creates a hostile environment for neural development. Critically, the loss of neurogenic capacity precedes significant neuronal death in many AD models, suggesting that impaired neurogenesis may represent an early pathological event contributing to memory dysfunction before overt neuronal loss occurs (PMID:23063882). Recent longitudinal studies indicate that preserved hippocampal neurogenesis correlates with better cognitive outcomes in aged individuals, positioning neurogenesis enhancement as a potential neuroprotective strategy.
Neurogenesis decline is also implicated in other neurodegenerative conditions. In Parkinson's disease, neuroinflammation and oxidative stress suppress dopaminergic system development and hippocampal neurogenesis, potentially contributing to both motor and cognitive deficits. Huntington's disease pathology impairs BDNF signaling and transcriptional regulation necessary for proper neural progenitor development. Temporal lobe epilepsy exhibits paradoxically increased but dysregulated neurogenesis, wherein newly generated neurons exhibit aberrant migration and connectivity patterns, potentially contributing to continued seizure activity and progressive cognitive decline. These disease-specific alterations in neurogenesis reveal that the quantity, quality, and proper integration of newly generated neurons are all critical for maintaining cognitive and motor function (PMID:20685952).
The identification of neurogenesis dysregulation in multiple neurodegenerative diseases has spawned considerable therapeutic interest. Interventions promoting neurogenesis—including physical exercise, cognitive enrichment, dietary approaches (notably caloric restriction and polyphenol intake), and pharmacological agents targeting signaling pathways critical for neural progenitor development—show promise for slowing cognitive decline. Emerging evidence suggests that combination therapies simultaneously addressing multiple aspects of neurogenesis (proliferation, differentiation, and survival) may prove more effective than single-target approaches. Additionally, the discovery that newborn neurons remain functionally plastic throughout their maturation period suggests temporal windows for therapeutic intervention, wherein promoting neurogenesis during critical periods might be particularly efficacious.
• Mechanistic Studies of Neuroinflammation and Neurogenesis: Recent research increasingly focuses on understanding how neuroinflammatory signaling—particularly through TLR4, IL-1β, and TNFα pathways—suppresses neural stem cell function in neurodegenerative disease contexts. Advanced single-cell RNA sequencing approaches are revealing cell-type-specific transcriptomic changes in neurogenic niches during disease progression, identifying novel therapeutic targets. Emerging evidence for crosstalk between microglial activation, astrocyte dysfunction, and NSC regulation is reshaping our understanding of how systemic inflammation impacts brain-intrinsic regenerative capacity (PMID:26951744).
• Translational Development of Neurogenesis-Enhancing Therapeutics: Multiple clinical trials are now evaluating whether enhancing neurogenesis through targeted interventions improves cognitive outcomes in AD and other neurodegenerative diseases. Recent focus areas include small molecules promoting NSC proliferation or differentiation, biologics including BDNF and related neurotrophic factors, and lifestyle-based interventions with mechanistic monitoring via neuroimaging biomarkers. The challenge remains identifying interventions that specifically enhance beneficial neurogenesis while avoiding potential complications from dysregulated proliferation.
• Advanced Imaging and Functional Characterization of Newborn Neurons: Novel neuroimaging techniques, including two-photon microscopy in awake behaving animals and functional connectivity neuroimaging in humans, are enabling unprecedented characterization of how newly generated neurons functionally integrate into existing circuits. Optogenetic and chemogenetic approaches allow selective manipulation of newborn neuron populations to determine their causal contribution to specific cognitive processes and behavioral outcomes. These tools are essential for validating whether neurogenesis enhancement therapeutically translates into functional improvement in disease contexts (PMID:24990962).
PMID:17873885 - Foundational review on neural stem cell biology and mechanisms of neurogenesis regulation
PMID:23658582 - Pattern separation and the specific role of immature neurons in hippocampal-dependent cognition
PMID:21068766 - Activity-dependent integration of newborn hippocampal neurons and memory formation
PMID:16618002 - Comprehensive review of environmental and physiological factors regulating adult neurogenesis
PMID:19147841 - Olfactory bulb neurogenesis and sensory system integration
PMID:23063882 - Neurogenesis dysregulation in Alzheimer's disease models and cognitive decline
PMID:20685952 - Neurogenesis abnormalities across multiple neurodegenerative disease states
PMID:26951744 - Neuroinflammatory mechanisms of neurogenesis suppression in disease
PMID:24990962 - Advanced methodologies for functional characterization of newborn neurons
The following diagram shows the key molecular relationships involving Neurogenesis discovered through SciDEX knowledge graph analysis:
The following diagram shows the key molecular relationships involving Neurogenesis discovered through SciDEX knowledge graph analysis: